Effectiveness of PeeRelease - a Gel Absorbent Pad in Moderate to Severe Urinary Incontinence
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of the proposed study is to test the effect of the new gel pad on the quality of life of urinary incontinent men and women and to assess to what extent the gel pad improves the quality of life of incontinence persons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 4, 2010
CompletedFirst Posted
Study publicly available on registry
February 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedFebruary 10, 2010
February 1, 2010
3 months
February 4, 2010
February 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Significant improvement in quality of life for men and women who use the new gel pad in comparison to usage of existing solutions; this means a difference of at least 5 scores on the 1-100 I-QoL score scale
two weeks
Secondary Outcomes (2)
Pad weight and number of pads used per day
daily
Observation for any development of rash due to patients' sensitivity to the pad
two weeks
Interventions
A larger gel containing pad was developed, suitable to absorb up to half a liter liquid, it eliminates odors and enables the users to wear ordinary clothes
Eligibility Criteria
You may qualify if:
- Urinary incontinent women and men who loose urine at a quantity higher than drops (50CC or more).
- Three segments of such persons will be included in the study:
- pregnant women who are temporary urinary incontinent
- women of the age 40+ who are urinary incontinent
- men who are urinary incontinent (post prostatectomy)
You may not qualify if:
- Urinary incontinent disabled patients who need nursing
- Patients who presently have cancer of any kind,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tisteron Ltd.lead
Study Sites (1)
Rabin Medical Center
Petah Tikva, 49100, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 4, 2010
First Posted
February 10, 2010
Study Start
February 1, 2010
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
February 10, 2010
Record last verified: 2010-02